Posts

Showing posts from 2026
Show all
Image

EU Joint Clinical Assessment after the first reports: How should companies interpret the findings?

Image

England’s Single National Formulary: Win-Win Reform or New Market Access Bottleneck?

Image

Anti-Amyloid Drugs in Alzheimer’s: Breakthrough, Dead End, or Reimbursement Reality Check?

Image

MFN Pricing and the “Global Launch Freeze”: A More Measured Perspective